[1]Rodríguez-Fraile M, Cózar-Santiago MP, Sabaté-Llobera A, et al. FDG PET/CT in colorectal cancer[J]. Rev Esp Med Nucl Imagen Mol (Engl Ed), 2020, 39:57-66. [2]Chetty R, McCarthy AJ. Neoadjuvant chemoradiation and rectal cancer[J]. J Clin Pathol, 2019, 72:97-101. [3]代群, 葛宇清. 桔梗皂苷D联合伊马替尼对白血病耐药细胞K562/R的抑制增殖和作用机制研究[J]. 中国中药杂志, 2018, 43:385-389. [4]刘学刚, 刘艳彩, 吴春平, 等. 白细胞分化抗原151促进人结直肠癌细胞系HT29的增殖及侵袭[J]. 基础医学与临床, 2020, 40:1626-1630. [5]Zhou F, Wang L, Jin K, et al. RecQ-like helicase 4 (RECQL4) exacerbates resistance to oxaliplatin in colon adenocarcinoma via activation of the PI3K/AKT signaling pathway[J]. Bioengineered, 2021, 12:5859-5869. [6]马琳琳, 何慧, 张世科, 等. 桔梗皂苷-D诱导Hela细胞凋亡的作用及机制研究[J]. 现代中西医结合杂志, 2020, 29:2429-2436. [7]赵若琳, 周坤福, 张旭, 等. 桔梗皂苷-D诱导肺腺癌A549和A549/DDP细胞凋亡和周期阻滞[J]. 辽宁中医杂志, 2015, 42:1484-1489. [8]Liu A, Wu Q, Peng D, et al. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation[J]. Med Res Rev, 2020, 40:1973-2018. [9]Deng Y, Guo W, Xu N, et al. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells[J]. Mol Carcinog, 2020, 59:512-519. [10]Liu Q, Wang K. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin[J]. Cell Biol Int, 2019, 43:1245-1256. [11]荆薇, 宋娜, 侯科佐, 等. DNMT3a通过STAT3及RAD51影响胰腺癌细胞对奥沙利铂敏感性的研究[J]. 现代肿瘤医学, 2018, 26:2325-2330. |